Drug Trial Radar · NCT05827146
Study of Hepalatide in Chronic Hepatitis D(CHD) Patients
Last checked: Nov 19, 2026Latest source record: Apr 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
23
Actual
Start
Oct 7, 2023
Primary completion
Jan 30, 2024
Study completion Feb 1, 2024
Sponsor
- Lead sponsor
- Shanghai HEP Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase 2a clinical Study of Hepalatide for Injection in Subjects with Chronic Hepatitis D
Conditions
- Chronic Hepatitis D Infection
Interventions
HepalatideDrug
Either the placebo or hepalatide (2.1 mg, 4.2 mg, or 6.3 mg) will be given for 4 consecutive weeks. s.c., once daily.
Hepalatide PlaceboDrug
Either the placebo or hepalatide (2.1 mg, 4.2 mg, or 6.3 mg) will be given for 4 consecutive weeks. s.c., once daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Hepatitis D Virus(HDV) RNA levelTime frame: Week 4
Locations
3 sites in 2 countries. Site status is shown where the registry gives one.
The first hospital of Jilin University
Changchun, China
The first affiliated hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
the National cancer center of Mongolia
Ulaanbaatar, Mongolia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.